GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Karolinska Development AB (FRA:2I9) » Definitions » Current Accrued Expense

Karolinska Development AB (FRA:2I9) Current Accrued Expense : €0.00 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Karolinska Development AB Current Accrued Expense?

Karolinska Development AB's Current Accrued Expense for the quarter that ended in Sep. 2024 was €0.00 Mil.


Karolinska Development AB Current Accrued Expense Historical Data

The historical data trend for Karolinska Development AB's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karolinska Development AB Current Accrued Expense Chart

Karolinska Development AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Karolinska Development AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Karolinska Development AB Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Karolinska Development AB Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Karolinska Development AB's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Karolinska Development AB Business Description

Traded in Other Exchanges
Address
TomtebodavAgen 23 A, Solna, SWE, SE-171 65
Karolinska Development AB is a life science investment company. It is focused on identifying breakthrough medical innovations in the Nordic region. It selects commercially attractive medical innovations, develops innovations to the stage where the return on investment can be achieved, and commercializes the innovations through the sale of companies or out-licensing of products. The company focused on profiles namely Aprea Therapeutics; Modus Therapeutics; BioArctic; Umecrine Cognition; and OssDsign.

Karolinska Development AB Headlines

No Headlines